Join Dr. Narjust Florez as she explores complementary and integrative medicine in lung cancer care with leading experts Dr. Ting Bao, Dr. Jun J. Mao, and Dr. Lisa Davis. This episode clarifies the differences between alternative, complementary, and integrative approaches while addressing oncologists' concerns about safety and drug interactions. Learn where to find reliable information, what the research shows about treatments like acupuncture and supplements, and how patients can safely incorporate these therapies into their cancer journey.
Guests:
Ting Bao, MD, MS, FSIO
Co-Director, Leonard P. Zakim Center for Integrative Therapies and Healthy Living
Member of the Faculty, Harvard Medical School
Dana-Farber Cancer Institute
Jun J. Mao, MD, MSCE
Chief, Integrative Medicine Service
Laurance S. Rockefeller Chair in Integrative Medicine
Professor of Medicine, Weill Cornell Medicine
Memorial Sloan Kettering Cancer Center
Lisa Davis, PharmD, FCCP, BCPS, BCOP,
Clinical Professor, Pharmacy Practice & Science
The University of Arizona, R. Ken Coit College of Pharmacy
All content for Lung Cancer Considered is the property of IASLC and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join Dr. Narjust Florez as she explores complementary and integrative medicine in lung cancer care with leading experts Dr. Ting Bao, Dr. Jun J. Mao, and Dr. Lisa Davis. This episode clarifies the differences between alternative, complementary, and integrative approaches while addressing oncologists' concerns about safety and drug interactions. Learn where to find reliable information, what the research shows about treatments like acupuncture and supplements, and how patients can safely incorporate these therapies into their cancer journey.
Guests:
Ting Bao, MD, MS, FSIO
Co-Director, Leonard P. Zakim Center for Integrative Therapies and Healthy Living
Member of the Faculty, Harvard Medical School
Dana-Farber Cancer Institute
Jun J. Mao, MD, MSCE
Chief, Integrative Medicine Service
Laurance S. Rockefeller Chair in Integrative Medicine
Professor of Medicine, Weill Cornell Medicine
Memorial Sloan Kettering Cancer Center
Lisa Davis, PharmD, FCCP, BCPS, BCOP,
Clinical Professor, Pharmacy Practice & Science
The University of Arizona, R. Ken Coit College of Pharmacy
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of maintenance lurbinectedin plus atezolizumab for extensive stage small cell lung cancer, based on the phase III IMforte trial. Dr. Hossein Borghaei joins the podcast to explain the results and offer perspective on the impact of maintenance therapy for SCLC.
Guest:
Dr. Hossein Borghaei, DO, MS
Chief, Division of Thoracic Medical Oncology
Professor, Department of Hematology/Oncology
Fox Chase Cancer Center
Lung Cancer Considered
Join Dr. Narjust Florez as she explores complementary and integrative medicine in lung cancer care with leading experts Dr. Ting Bao, Dr. Jun J. Mao, and Dr. Lisa Davis. This episode clarifies the differences between alternative, complementary, and integrative approaches while addressing oncologists' concerns about safety and drug interactions. Learn where to find reliable information, what the research shows about treatments like acupuncture and supplements, and how patients can safely incorporate these therapies into their cancer journey.
Guests:
Ting Bao, MD, MS, FSIO
Co-Director, Leonard P. Zakim Center for Integrative Therapies and Healthy Living
Member of the Faculty, Harvard Medical School
Dana-Farber Cancer Institute
Jun J. Mao, MD, MSCE
Chief, Integrative Medicine Service
Laurance S. Rockefeller Chair in Integrative Medicine
Professor of Medicine, Weill Cornell Medicine
Memorial Sloan Kettering Cancer Center
Lisa Davis, PharmD, FCCP, BCPS, BCOP,
Clinical Professor, Pharmacy Practice & Science
The University of Arizona, R. Ken Coit College of Pharmacy
